Stay updated with breaking news from Eva Kalias. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera Announces Corporate Calendar Update
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, June 3, 2022 -- Santhera Pharmaceuticals (SIX: SANN) has updated its corporate calendar. The Company will publish its 2021 Annual Report
Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera Announces Improved Liquidity Position
Ad hoc announcement pursuant to Art. 53 LR Restructured timing of ReveraGen milestone payments, reducing near-term liquidity needsSecured up to CHF 40 million of additional financing
Pratteln, Switzerland, and Rockville, MD, USA, March 15, 2022 - Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce presentations of efficacy and tolerability data with vamorolone